A cross sectional study of drug resistant tuberculosis in previously treated cases.

A. Punjabi (MUMBAI (MAHARASHTRA), India)

Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Session: Microbiology and laboratory techniques to monitor NTM infections
Session type: Thematic Poster
Number: 2739
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Punjabi (MUMBAI (MAHARASHTRA), India). A cross sectional study of drug resistant tuberculosis in previously treated cases.. 2739

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The prevalence of drug resistance tuberculosis in previously treated patients
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008

Multicentre randomised clinic study of new standard chemotherapy regimen for new cases patients of pulmonary tuberculosis executed in Russia regions with high level of multiple drug resistance (MDR)
Source: Annual Congress 2009 - Tuberculosis control
Year: 2009

Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007



Bedaquiline containing regimens for the treatment of multi- and extensively drug-resistant tuberculosis at the programmatic level in Belarus. Prospective cohort study.
Source: International Congress 2019 – Drug-resistant tuberculosis
Year: 2019



Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre
Source: Eur Respir J 2003; 22: Suppl. 45, 524s
Year: 2003

First countrywide observational study of acquired drug resistance among TB cases in Ukraine
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Treatment of MDR tuberculosis in Switzerland. A case control study
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011

Multi-drug resistant tuberculosis: a retrospective analysis of cases over 10 years in a low incidence setting
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007


Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation
Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB)
Year: 2006


A study of prescription of second line drugs in chronic tuberculosis patients before confirmation of multi drug resistance bacteriologically
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010


Our experience in multi drug resistant tuberculosis (MDR TB) treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

When, where, and how to treat tuberculosis in multiple drug resistant patients
Source: International Congress 2016 – PG10 Tuberculosis management: a personalised clinical approach
Year: 2016



Resistance of Mycobacterium tuberculosis to the first-line (MDR) and second line (XDR) anti tuberculosis drugs in the south western zone of Nigeria: A- 3 year retrospective study
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Frequency of side effects among patients with drug resistant tuberculosis (DR-TB) by resistance pattern in a high burden country.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Clinical and mutational profile of extensively drug resistant tuberculosis cases in northern India.
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021


Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002

Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 548s
Year: 2002

Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence
Source: Eur Respir J 2013; 42: 288-290
Year: 2013


Prospective study of mycobacterium tuberculosis drug resistance in Tunisia
Source: Eur Respir J 2004; 24: Suppl. 48, 658s
Year: 2004

Radiologic pattern as a predictor of multi-drug resistant tuberculosis; a multicenter study.
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019